Clinical Trial Update: Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 1/2 neoadjuvant study of dupilumab plus toripalimab in microsatellite-stable metastatic colorectal cancer with resectable live…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• DUPIXENT (DUPILUMAB)
• Tuoyi (toripalimab)

Snippet

Sponsor: Dan Feng | Conditions: Metastatic Colorectal Cancer, Liver Metastases | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING